WDR5 is a conserved regulator of protein synthesis gene expression
Audra F. Bryan(Vanderbilt University), William P. Tansey(Vanderbilt University), Eric J. Rellinger(University of Kentucky), Qi Liu(East China University of Science and Technology), Dai H. Chung(The University of Texas Southwestern Medical Center), Brittany K. Matlock(Vanderbilt University Medical Center), April M. Weissmiller(Middle Tennessee State University), Alissa D. Guarnaccia(Vanderbilt University), Chase M. Woodley(Vanderbilt University), David K. Flaherty(Vanderbilt University Medical Center), Shelly L. Lorey(Vanderbilt University), Erin R. Aho(Vanderbilt University), Stephen W. Fesik(Vanderbilt University), Jing Wang(Shihezi University), Gregory C. Howard(Vanderbilt University)
Cited by 89
Related Papers
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
|Cancer Research|2008|2k
Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of Cancer
|Journal of Medicinal Chemistry|2004|364
Influence of Bcl-2 Family Members on the Cellular Response of Small-Cell Lung Cancer Cell Lines to ABT-737
|Cancer Research|2007|302
Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xL
|Journal of Medicinal Chemistry|2007|295